January 2016 Monthly Test Updates

Published on 01/04/16

New Test Updates

The below test updates are live:
  • EG Duchenne/Becker Muscular Dystrophy: DMD Gene Deletion/Duplication – Methodology update
  • MM205 High Risk Colorectal Cancer: Sequencing Panel – 2016 CPT Code Update
  • MD205 High Risk Colorectal Cancer: Deletion/Duplication Panel – 2016 CPT Code Update
  • MM209 Gastrointestinal and Colorectal Cancer: Sequencing Panel – 2016 CPT Code Update
  • MD209 Gastrointestinal and Colorectal Cancer: Deletion/Duplication Panel – 2016 CPT Code Update
  • SNRAS Noonan Syndrome: NRAS Gene Sequencing – 2016 CPT Code Update
  • CM080 Targeted Tumor Mutation: Sequencing Panel – 2016 CPT Code Update
  • CM081 Targeted Colorectal Tumor Mutation: Sequencing Panel – 2016 CPT Code Update
  • CM082 Targeted Lung Tumor Mutation: Sequencing Panel – 2016 CPT Code Update
  • CM083 Targeted Melanoma Mutation: Sequencing Panel – 2016 CPT Code Update
  • CM084 Targeted Gastric Tumor Mutation: Sequencing Panel – 2016 CPT Code Update
  • CM085 Targeted Ovarian Tumor Mutation: Sequencing Panel – 2016 CPT Code Update
  • MNOO1 Noonan Syndrome and Related Disorders: Sequencing Panel – 2016 CPT Code Update
  • MM401 Melanoma: Sequencing Panel – 2016 CPT Code Update
  • MM520 Cardiomyopathy: Sequencing Panel – 2016 CPT Code Update
  • MCAR1 Comprehensive Cardiovascular: Sequencing Panel – 2016 CPT Code Update
  • MM070 Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing and Deletion/Duplication Panel – 2016 CPT Code Update
  • MM071 Hereditary Breast and Ovarian Cancer Syndrome: BRCA1/BRCA2 Gene Sequencing Panel – 2016 CPT Code Update
  • BB021 Autism Spectrum Disorders: Tier 1 Biochemical Panel – 2016 CPT Code Update
  • GA Mucopolysaccharidosis:  Glycosaminoglycans (GAGs), Quantitative and Qualitative, Urine – 2016 CPT Code Update
  • BLSDS Lysosomal Storage Disorders: Urine Screening – 2016 CPT Code Update
  • XC020 Autism Spectrum Disorders: Complete Tier 1 Panel – 2016 CPT Code Update
  • HO Homocysteine, Total Quantitative, Plasma – 2016 CPT Code Update
  • BNBSF NBS Follow-up: Panel Methylmalonic Acidemia (MMA)/Propionic Acidemia (PA) – 2016 CPT Code Update
  • BB041 Rhabdomyolysis: Tier 2 Panel – 2016 CPT Code Update
  • BHOBS Homocysteine, Total Quantitative, Dried Blood Spot – 2016 CPT Code Update
  • BMMAD Methylmalonic Acid and Methylcitric Acid, Quantitative, Dried  Blood Spot – 2016 CPT Code Update
  • MW Metabolic Disease: Panel (AA, AR, CN, OA) – 2016 CPT Code Update
  • BGBCU Fabry Disease: Globotriaosylceramide (Gb3) Quantification, Urine – 2016 CPT Code Update
  • BCAHP Congenital Adrenal Hyperplasia: Steroid Profile, Quantitative, Dried Blood Spot – 2016 CPT Code Update
  • BCDGP Congenital Disorders of Glycosylation: Panel, Carbohydrate Deficient Transferrin Analysis and N-Glycan Profile, Plasma – 2016 CPT Code Update
  • BNGLY Congenital Disorders of Glycosylation: N-Glycan Profile, Qualitative, Plasma – 2016 CPT Code Update
  • BOGLY Congenital Disorders of Glycosylation: O-glycan Analysis, Quantitative and Qualitative, Plasma – 2016 CPT Code Update
  • OS Oligosaccharidosis and Congenital Disorders of Glycosylation: High resolution Oligosaccharide (Free Glycan) Profile, Urine – 2016 CPT Code Update
  • XB040 Rhabdomyolysis: Tier 1 Panel – 2016 CPT Code Update
  • KC Carnitine Deficiency, Primary (Carnitine Uptake Defect): SLC22A5 Gene Sequencing – CPT Code Update
  • MM550 Dystonia: Sequencing Panel – Added COL6A3 and PLA2G6
  • TC Tissue Culture Only – Name changed to "Establish A Culture (Not Prenatal)"

Test Requisitions - Things to Remember
Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD10 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition.
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.


Prior Authorization Reminder
When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.